JP Morgan Chase’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.03M Buy
350,571
+200,769
+134% +$4.32M ﹤0.01% 2882
2025
Q4
$2.99M Sell
149,802
-69,161
-32% -$1.35M ﹤0.01% 3765
2025
Q3
$4M Sell
218,963
-30,435
-12% -$593K ﹤0.01% 3554
2025
Q2
$5.01M Sell
249,398
-41,509
-14% -$798K ﹤0.01% 3169
2025
Q1
$5.27M Buy
290,907
+6,521
+2% +$117K ﹤0.01% 3113
2024
Q4
$4.93M Sell
284,386
-293,857
-51% -$5.64M ﹤0.01% 3356
2024
Q3
$11.2M Buy
578,243
+72,039
+14% +$1.33M ﹤0.01% 2506
2024
Q2
$8.3M Buy
506,204
+368,845
+269% +$5.72M ﹤0.01% 2617
2024
Q1
$2.09M Sell
137,359
-191,848
-58% -$3.01M ﹤0.01% 3808
2023
Q4
$5.28M Buy
329,207
+9,006
+3% +$126K ﹤0.01% 3039
2023
Q3
$4.16M Sell
320,201
-1,974
-0.6% -$25.6K ﹤0.01% 2972
2023
Q2
$4.1M Buy
322,175
+22,242
+7% +$278K ﹤0.01% 3030
2023
Q1
$3.37M Sell
299,933
-35,643
-11% -$432K ﹤0.01% 3127
2022
Q4
$4.45M Buy
335,576
+26,518
+9% +$349K ﹤0.01% 2928
2022
Q3
$3.59M Sell
309,058
-67,942
-18% -$932K ﹤0.01% 3015
2022
Q2
$5.56M Buy
377,000
+70,203
+23% +$1.15M ﹤0.01% 2701
2022
Q1
$5.94M Buy
306,797
+27,181
+10% +$486K ﹤0.01% 2859
2021
Q4
$4.82M Buy
279,616
+38,157
+16% +$650K ﹤0.01% 3089
2021
Q3
$4.04M Sell
241,459
-91,656
-28% -$1.37M ﹤0.01% 3213
2021
Q2
$4.47M Buy
333,115
+133,692
+67% +$1.67M ﹤0.01% 3152
2021
Q1
$2.38M Buy
199,423
+50,784
+34% +$614K ﹤0.01% 3585
2020
Q4
$1.84M Buy
148,639
+105,381
+244% +$1.14M ﹤0.01% 3538
2020
Q3
$447K Sell
43,258
-90,756
-68% -$1.15M ﹤0.01% 4036
2020
Q2
$1.87M Buy
134,014
+102,663
+327% +$1.4M ﹤0.01% 3148
2020
Q1
$370K Sell
31,351
-351
-1% -$4.64K ﹤0.01% 3970
2019
Q4
$449K Sell
31,702
-158,402
-83% -$1.94M ﹤0.01% 4287
2019
Q3
$2M Buy
190,104
+16,104
+9% +$193K ﹤0.01% 3416
2019
Q2
$2.48M Buy
174,000
+147,463
+556% +$2.09M ﹤0.01% 3233
2019
Q1
$373K Sell
26,537
-51
-0.2% -$826 ﹤0.01% 4347
2018
Q4
$464K Sell
26,588
-999,732
-97% -$16.2M ﹤0.01% 4165
2018
Q3
$15.6M Buy
1,026,320
+659,372
+180% +$9.49M ﹤0.01% 1850
2018
Q2
$5.06M Buy
366,948
+215,746
+143% +$3.23M ﹤0.01% 2674
2018
Q1
$2.52M Sell
151,202
-272,428
-64% -$4.2M ﹤0.01% 3100
2017
Q4
$6.01M Sell
423,630
-356,916
-46% -$4.76M ﹤0.01% 2534
2017
Q3
$10.9M Buy
780,546
+727,803
+1,380% +$9.62M ﹤0.01% 1920
2017
Q2
$675K Sell
52,743
-67,584
-56% -$848K ﹤0.01% 3606
2017
Q1
$1.66M Sell
120,327
-50,306
-29% -$592K ﹤0.01% 3149
2016
Q4
$1.83M Buy
+170,633
New +$1.79M ﹤0.01% 3124
2016
Q3
Sell
-7,024
Closed -$74K 4667
2016
Q2
$74K Sell
7,024
-6,960
-50% -$82.3K ﹤0.01% 3939
2016
Q1
$176K Buy
13,984
+980
+8% +$10.8K ﹤0.01% 3645
2015
Q4
$137K Buy
+13,004
New +$120K ﹤0.01% 3732
2014
Q2
Sell
-19,993
Closed -$498K 3566
2014
Q1
$498K Sell
19,993
-773
-4% -$22.6K ﹤0.01% 3135
2013
Q4
$596K Sell
20,766
-92,136
-82% -$2.7M ﹤0.01% 3397
2013
Q3
$3.72M Sell
112,902
-16,452
-13% -$512K ﹤0.01% 2384
2013
Q2
$4.02M Buy
+129,354
New +$3.47M ﹤0.01% 2282

Other funds holding INVA

JP Morgan Chase's INVA Position: Q1 2026 in Review

JP Morgan Chase increased its Innoviva (INVA) stake by 134% in Q1 2026, buying an estimated $4.32M and bringing the position to 350,571 shares worth $8.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2882.

JP Morgan Chase first reported a position in INVA in Q2 2013 and has held it in 45 quarters since. The position peaked at $15.6M in Q3 2018. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • JP Morgan Chase held 350,571 shares of Innoviva worth $8.03M as of Q1 2026.
  • JP Morgan Chase bought 200,769 Innoviva shares in Q1 2026, an estimated $4.32M.
  • Innoviva made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2882 holding.
  • JP Morgan Chase first reported a position in Innoviva in Q2 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's Innoviva position peaked at $15.6M in Q3 2018.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.